1.42Open1.42Pre Close9 Volume281 Open Interest23.50Strike Price1.31KTurnover58.12%IV0.88%PremiumNov 22, 2024Expiry Date1.36Intrinsic Value100Multiplier4DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type0.8381Delta0.1664Gamma16.57Leverage Ratio-0.0500Theta0.0020Rho13.89Eff Leverage0.0062Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet